Thorsten Berg
Impact in
- Oncology top 2%
- Cytokine Signaling Pathways and Interactions
- Cancer-related Molecular Pathways
- Cell Biology top 2%
- Microtubule and mitosis dynamics
Papers in
-
- Ubiquitin and proteasome pathways 19
- Chemical Synthesis and Analysis 9
- PI3K/AKT/mTOR signaling in cancer 9
- Protein Degradation and Inhibitors 7
- Oncology 39
- Cytokine Signaling Pathways and Interactions 25
- Cancer-related Molecular Pathways 10
- Co-authors
- Bianca Sperl (12 shared papers)Angela Hollis (3 shared papers)Thomas U. Mayer (1 shared paper)Wolfgang Reindl (8 shared papers)Klaus Strebhardt (7 shared papers)Juping Yuan (4 shared papers)Andrea Krämer (3 shared papers)Angela Berg (14 shared papers)
- Journals
- ChemBioChem (16 papers)Angewandte Chemie International Edition (11 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Analytical Biochemistry (4 papers)ACS Chemical Biology (4 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Thorsten Berg
91 papers receiving 3.6k citations
Thorsten Berg's Hit Papers
Peers
Comparison fields: 5 of 107
- Oncology 1.5k
- Cell Biology 634
- Molecular Biology 2.3k
- Toxicology 102
- Immunology 479
Countries citing papers authored by Thorsten Berg
This map shows the geographic impact of Thorsten Berg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thorsten Berg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thorsten Berg more than expected).
Fields of papers citing papers by Thorsten Berg
This network shows the impact of papers produced by Thorsten Berg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thorsten Berg. The network helps show where Thorsten Berg may publish in the future.
Co-authors
The 25 scholars most cited alongside Thorsten Berg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 93 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Stattic: A Small-Molecule Inhibitor of STAT3 Activation and Dimerization Hit paper breakdown → | 2006 | 875 |
| 2 | 2002 | 261 | |
| 3 | 2003 | 254 | |
| 4 | 2008 | 185 | |
| 5 | 2006 | 120 | |
| 6 | 2008 | 118 | |
| 7 | 2011 | 96 | |
| 8 | 2008 | 94 | |
| 9 | 2004 | 88 | |
| 10 | 2012 | 88 | |
| 11 | 2011 | 75 | |
| 12 | 2007 | 69 | |
| 13 | 2009 | 55 | |
| 14 | 2015 | 55 | |
| 15 | 2015 | 52 | |
| 16 | 2008 | 51 | |
| 17 | 2010 | 47 | |
| 18 | 2009 | 41 | |
| 19 | 2008 | 41 | |
| 20 | 2003 | 40 |
About Thorsten Berg
Thorsten Berg is a scholar working on Molecular Biology, Oncology, Cell Biology, Organic Chemistry and Immunology, having authored 93 papers that have together received 3.6k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (25 papers), Ubiquitin and proteasome pathways (19 papers), Microtubule and mitosis dynamics (18 papers), Cancer-related Molecular Pathways (10 papers), Chemical Synthesis and Analysis (9 papers), PI3K/AKT/mTOR signaling in cancer (9 papers), Protein Degradation and Inhibitors (7 papers) and Microbial Natural Products and Biosynthesis (7 papers). The work is most often cited by research in Oncology (1.5k citations), Cell Biology (634 citations), Molecular Biology (2.3k citations), Toxicology (102 citations) and Immunology (479 citations). Thorsten Berg has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Bianca Sperl, Angela Hollis, Thomas U. Mayer, Wolfgang Reindl, Klaus Strebhardt, Juping Yuan, Andrea Krämer, Angela Berg, Stefan Rubner and Judith Müller. Their work appears in journals such as ChemBioChem, Angewandte Chemie International Edition, Bioorganic & Medicinal Chemistry Letters, Analytical Biochemistry and ACS Chemical Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.